Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16709854rdf:typepubmed:Citationlld:pubmed
pubmed-article:16709854lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C1333899lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C1325804lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C0019728lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C0282580lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C0376545lld:lifeskim
pubmed-article:16709854lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:16709854pubmed:issue11lld:pubmed
pubmed-article:16709854pubmed:dateCreated2006-5-19lld:pubmed
pubmed-article:16709854pubmed:abstractTextThe oncofetal Ag immature laminin receptor (OFA-iLR) is a potential target molecule for immunotherapeutic studies in several tumor entities, including hematological malignancies. In the present study, we characterize two HLA-A*0201-presented epitopes eliciting strong OFA-iLR peptide-specific human cytotoxic T cell (CTLs) responses in vitro. Both allogeneic HLA-A*0201-matched and autologous CTLs recognized and killed endogenously OFA-iLR-expressing tumor cell lines and primary malignant cells from patients with hemopoietic malignancies in an MHC-restricted fashion but spared nonmalignant hemopoietic cells. Spontaneous OFA-iLR peptide-specific T cell reactivity was detectable in a significant proportion of leukemia patients. Interestingly, in patients with chronic lymphocytic leukemia and multiple myeloma but not in those with acute myeloid leukemia, significant frequencies of OFA peptide-specific CTLs could be detected in an early stage of disease but disappeared in patients with progressive disease. The identification of OFA-iLR-derived peptide epitopes provides a basis for tumor immunological studies and therapeutic vaccination strategies in patients with OFA-iLR-expressing malignancies.lld:pubmed
pubmed-article:16709854pubmed:languageenglld:pubmed
pubmed-article:16709854pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16709854pubmed:statusMEDLINElld:pubmed
pubmed-article:16709854pubmed:monthJunlld:pubmed
pubmed-article:16709854pubmed:issn0022-1767lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:RohrerJamesJlld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:SchmitzNorber...lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:KabelitzDiete...lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:WagnerAndreas...lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:ZeisMatthiasMlld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:SteinmannJörg...lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:DregerPeterPlld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:SiegelSandraSlld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:BarsoumAdelAlld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:FriedrichsBir...lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:WendelerAnnek...lld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:WendelLenaLlld:pubmed
pubmed-article:16709854pubmed:authorpubmed-author:CogginJosephJlld:pubmed
pubmed-article:16709854pubmed:issnTypePrintlld:pubmed
pubmed-article:16709854pubmed:day1lld:pubmed
pubmed-article:16709854pubmed:volume176lld:pubmed
pubmed-article:16709854pubmed:ownerNLMlld:pubmed
pubmed-article:16709854pubmed:authorsCompleteYlld:pubmed
pubmed-article:16709854pubmed:pagination6935-44lld:pubmed
pubmed-article:16709854pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:meshHeadingpubmed-meshheading:16709854...lld:pubmed
pubmed-article:16709854pubmed:year2006lld:pubmed
pubmed-article:16709854pubmed:articleTitleIdentification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.lld:pubmed
pubmed-article:16709854pubmed:affiliationGeneral Hospital St. Georg, Department of Hematology, Hamburg, Germany.lld:pubmed
pubmed-article:16709854pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:18290entrezgene:pubmedpubmed-article:16709854lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16709854lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16709854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16709854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16709854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16709854lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16709854lld:pubmed